List of Contract Manufacturing Companies in Spain - 10

3P Bio is a Biologics CDMO that assists in delivering advanced medicines for biologics journey.

We are now 3PBIOVIAN! 𝗙𝗼𝗹𝗹𝗼𝘄 𝘂𝘀 𝗼𝗻 𝗼𝘂𝗿 𝗻𝗲𝘄 𝗟𝗶𝗻𝗸𝗲𝗱𝗜𝗻 𝗽𝗮𝗴𝗲, 𝟯𝗣𝗕𝗜𝗢𝗩𝗜𝗔𝗡, 𝘁𝗼 𝘀𝘁𝗮𝘆 𝘂𝗽𝗱𝗮𝘁𝗲𝗱 𝗼𝗻 𝗮𝗹𝗹 𝘁𝗵𝗲 𝗹𝗮𝘁𝗲𝘀𝘁 𝗱𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁𝘀 𝗮𝗻𝗱 𝗻𝗲𝘄𝘀! 3P Biopharmaceuticals and Biovian join forces to create 3PBIOVIAN, a leading pan-European biologics CDMO. Read more here: www.3pbiovian.com ***** 3PBIOVIAN is a globally operating Contract Development and Manufacturing Organization (CDMO), delivering end-to-end services for biotech and pharma companies. Our service offering includes microbial and mammalian protein expression platforms, viral vector production for adenoviruses and adeno-associated viruses, cell therapy, and plasmid DNA production. Additionally, we provide fill and finish services for recombinant proteins and viral vectors. With a combined track record of 40 years in process development and analytical methods development, complemented by our experience in process scale-up, GMP manufacturing, and commercial supply, we are equipped to offer comprehensive manufacturing services at all stages, encompassing Drug Substance and Drug Product. Our manufacturing sites in Pamplona-Noáin, Spain, and Turku, Finland seamlessly support the diverse needs of our clients, covering pre-clinical and clinical supply to full-scale commercial manufacturing.

Curapath is a CDMO with expertise in developing novel drug delivery systems (DDS). What sets us apart is our analytical expertise in the formulation and manufacturing of Lipid nanoparticles (LNP) and Polymer nanoparticles (PNP). When you start working with Curapath, we can support your entire therapeutic journey from development to IND. Curapath supports GMP manufacturing of Drug Substance and Drug Product for clinical trial material. We provided unmatched technical support and analytical expertise in the custom design, development, and end-to-end GMP manufacturing of polymer and lipid-based drug delivery systems to support cell therapy, gene therapy, and vaccine delivery. For over a decade, Curapath has supported drug innovators in developing stealth shielding polymers (polyaminoacids), functional polymer & lipid excipients, linkers for bioconjugation, and API polymers used for therapeutics. Our history of success makes Curapath the right partner to drive your therapeutic development. We deliver consultative hands-on guidance from preclinical development through commercial-scale GMP manufacturing. Curapath is a knowledgeable partner you can trust to move fast, manufacture smart, and provide support through your drug development journey, accelerating your speed to the clinic. We help our partners solve even the most complex drug delivery challenges.

INSUD PHARMA operates across the entire pharmaceutical value chain, delivering specialized expertise and experience in scientific research, development, manufacturing, sales and marketing of a wide range of value-adding active pharmaceutical ingredients (APIs), finished dosage forms (FDFs) and branded pharmaceuticals, for human and animal health. While the main offices are located in Madrid, Lugano, Buenos Aires, INSUD PHARMA is acting worldwide, creating a broad and balanced manufacturing and commercial network across Europe, America, Asia and Africa, to address global opportunities and customers`​ needs in all major pharmaceutical markets. INSUD PHARMA's activity is organized in three synergistic business areas: Industrial (Chemo), Branded (Exeltis) and Biotech (mAbxience), with over 7,300 professionals in more than 50 countries, 18 state-of-the-art facilities, 15 specialized R&D centers, 12 commercial offices and more than 35 pharmaceutical affiliates, serving 1,150 customers in 96 countries around the world. INSUD PHARMA believes in innovation and sustainable development. Our commitment is to improve people`s health and quality of life, providing access to quality medicines at affordable prices, and to continuously expand our efforts and R&D investment to develop new and better therapies.

Reig Jofre is a Spanish pharmaceutical company founded in 1929 in Barcelona. It is currently led by the third generation of the Reig family and is listed on the Spanish Stock Exchange. The company employs over 1,100 people and operates in more than 70 countries through subsidiaries and partnerships. Reig Jofre specializes in pharmaceutical manufacturing, research and development, and commercialization, with production centers located in Barcelona, Toledo, and Sweden. The company offers contract manufacturing services, focusing on sterile injectables, beta-lactam antibiotics, and lyophilized products. It has partnered with Janssen to produce the COVID-19 vaccine and collaborates on various co-development projects. Reig Jofre's product range includes antibiotics, dermatology products utilizing patented technology, hospital injectables, and over-the-counter supplements. Recent developments include the opening of a new manufacturing plant in Barcelona and expansion into the South Korean market.

Rovi is a specialized pharmaceutical company engaged in the research, development, manufacture and marketing of pharmaceutical products. Their operations encompass the marketing of both their own and licensed products and the provision of services, such as production, filling and packaging, to other companies.

Nuestro equipo se dedica al desarrollo y comercialización de productos para la salud y el bienestar de las personas, a través de un servicio integral, soluciones innovadoras y productos de máxima calidad bajo normas GMP en: autocuidado, medicina de prescripción, cuidados hospitalarios y servicios especializados para terceros.

Suanfarma founded in 1993, is a B2B life science partner committed to health and innovation by developing, manufacturing, and distributing high quality ingredients for the pharmaceutical industry in an innovative and sustainable way. Suanfarma CDMO offers capacities for fermentation and chemical synthesis projects, providing a “One Stop Shop” service with a solid track record for the development, scaling, manufacturing, & commercialization of an API, either innovative or generic. All facilities comply with the highest existing regulations in the industry. We have a strong network of 12 local offices placed strategically globally, providing services to 400+ customers in 70+ countries.

Viralgen is a CDMOfor AAV production that supportslarge-scale manufacturing, fill-finish, and quality control in a GMP-certified environment